Cargando…

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma

Background: Lung adenocarcinoma (LUAD) is the major subtype of lung cancer and has a poor prognosis. Disulfidptosis is a novel regulated cell death form characterized by aberrant disulfide stress and actin network collapse. This study aimed to identify disulfidptosis-related lncRNAs, and predict LUA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hai-Bo, Pan, Jian-Yan, Zhu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563764/ https://www.ncbi.nlm.nih.gov/pubmed/37822882 http://dx.doi.org/10.3389/fphar.2023.1254119

Ejemplares similares

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma
por: Ni, Lina, et al.
Publicado: (2023)

A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer
por: Xiao, Lijun, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
por: Zhang, Mengzhe, et al.
Publicado: (2023)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhong, Fangmin, et al.
Publicado: (2023)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature
por: Yang, Zhuo, et al.
Publicado: (2023)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
por: Ma, Chao, et al.
Publicado: (2023)

The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma
por: Herrera-Merchan, Antonio, et al.
Publicado: (2017)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Disulfidptosis-associated lncRNAs predict breast cancer subtypes
por: Xia, Qing, et al.
Publicado: (2023)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

LncRNA LINC00588 Suppresses the Progression of Osteosarcoma by Acting as a ceRNA for miRNA-1972
por: Zhou, Fu-Chao, et al.
Publicado: (2020)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
por: Ma, Xiaoqing, et al.
Publicado: (2023)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

A novel autophagy‐related lncRNA survival model for lung adenocarcinoma
por: Wu, Liwei, et al.
Publicado: (2021)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)

Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma
por: Zhu, Ankang, et al.
Publicado: (2023)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2023)

A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma
por: Song, Jiahang, et al.
Publicado: (2021)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer
por: Song, Xuesong, et al.
Publicado: (2022)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
por: Dong, Hang, et al.
Publicado: (2019)

Prognostic value of antitumor drug targets prediction using integrated bioinformatic analysis for immunogenic cell death-related lncRNA model based on stomach adenocarcinoma characteristics and tumor immune microenvironment
por: Ding, Dayong, et al.
Publicado: (2022)

The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma
por: Qi, Cui, et al.
Publicado: (2023)

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
por: Zeng, Zhimin, et al.
Publicado: (2022)

A risk stratification and prognostic prediction model for lung adenocarcinoma based on aging-related lncRNA
por: Chen, HuiWei, et al.
Publicado: (2023)

A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma
por: Hu, Gunchu, et al.
Publicado: (2023)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
por: Shi, Chuan-jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s1flma1v9d093kkiqplcl2j4f0